Nature Communications (Nov 2016)

Increased DNA methylation variability in type 1 diabetes across three immune effector cell types

  • Dirk S. Paul,
  • Andrew E. Teschendorff,
  • Mary A.N. Dang,
  • Robert Lowe,
  • Mohammed I. Hawa,
  • Simone Ecker,
  • Huriya Beyan,
  • Stephanie Cunningham,
  • Alexandra R. Fouts,
  • Anita Ramelius,
  • Frances Burden,
  • Samantha Farrow,
  • Sophia Rowlston,
  • Karola Rehnstrom,
  • Mattia Frontini,
  • Kate Downes,
  • Stephan Busche,
  • Warren A. Cheung,
  • Bing Ge,
  • Marie-Michelle Simon,
  • David Bujold,
  • Tony Kwan,
  • Guillaume Bourque,
  • Avik Datta,
  • Ernesto Lowy,
  • Laura Clarke,
  • Paul Flicek,
  • Emanuele Libertini,
  • Simon Heath,
  • Marta Gut,
  • Ivo G Gut,
  • Willem H. Ouwehand,
  • Tomi Pastinen,
  • Nicole Soranzo,
  • Sabine E. Hofer,
  • Beate Karges,
  • Thomas Meissner,
  • Bernhard O. Boehm,
  • Corrado Cilio,
  • Helena Elding Larsson,
  • Åke Lernmark,
  • Andrea K. Steck,
  • Vardhman K. Rakyan,
  • Stephan Beck,
  • R. David Leslie

DOI
https://doi.org/10.1038/ncomms13555
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 11

Abstract

Read online

The incidence of type 1 diabetes is increasing, potentially implicating non-genetic factors. Here the authors conduct an epigenome-wide association study in disease-discordant twins and find increased DNA methylation variability at genes associated with immune cell metabolism and the cell cycle.